Sun Pharma Advanced Research Company Limited reported earnings results for the second quarter and six months ended September 30, 2022. For the second quarter, the company reported sales was INR 315.4 million compared to INR 278.7 million a year ago. Revenue was INR 316 million compared to INR 333.5 million a year ago. Net loss was INR 684 million compared to INR 551.4 million a year ago. Basic loss per share from continuing operations was INR 2.52 compared to INR 2.09 a year ago.
For the six months, sales was INR 600 million compared to INR 498.6 million a year ago. Revenue was INR 602.4 million compared to INR 561.4 million a year ago. Net loss was INR 1,507.5 million compared to INR 1,165.1 million a year ago. Basic loss per share from continuing operations was INR 5.54 compared to INR 4.44 a year ago.